Immuneel Therapeutics

Immuneel Therapeutics

Immuneel Therapeutics is focused on developing advanced cell and gene therapies, particularly CAR-T therapies for cancer treatment. The company aims to make these therapies accessible and affordable, targeting patients in India and emerging markets. This funding round will help scale their manufacturing capacity and support international expansion.

Total raised
$22.5M
across 2 rounds
Latest round
Series B
Jun 8, 2026
Known investors
5
led by Singularity AMC
Press coverage
7
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund Health startups in India.

Claim this profile →

🏆 Featured in Datapile’s Q2 2026 India Funding Report

Read the Q2 2026 India report →
Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-india-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 India Funding Report</a>

Funding history

  1. 2
    $12MSeries BJun 8, 2026

    Led by Singularity AMC

    Announcement ↗
  2. 1
    $10.5MSeries BJun 8, 2026
    Announcement ↗

Founder

Kiran Mazumdar-Shaw
Kiran Mazumdar-Shaw
Co-founder

Investors in Immuneel Therapeutics

Backers from this company's tracked funding rounds.

  • SSingularity AMCLead investorVC firm
  • RRainmatter by ZerodhaVC firm
  • KKiran Mazumdar-ShawAngel
  • EEight Roads VenturesVC firm
  • FF-Prime CapitalVC firm

Immuneel Therapeutics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile